Australia's largest stock trading and investment forum Australia's #1 stock forum

UNS unilife corporation

0.00%

0.5¢

Dupilumab gets FDA approval, page-9

First 9 Last

Share
Profile

Follow
Wyckoff

81 Posts.

29/03/17

23:28

Post #: 23723460
Share

Originally posted by Unifollower ↑

Thanks 009 for clearing this up but I believe that was what I was stumbling apon- that Amgen seem to have patented the entire PCSK9 enzyme.
(PCSK9) is an enzyme encoded by the PCSK9 gene in humans on chromosome)
I am hopeful that the courts will disallow Amgen's patent based on its broad nature and possibility of trying to patent part of DNA functions.

Unilifes Teneo range all have Bluethooth available if the Pharma wants it, but if the treatment is for 16 weeks it may not be worth the cost of the Pharma supplying it (excess $200) as against the patient having to inject it (phobia/pain)
The longer term of injections the Teneo becomes cheaper on a cost per injection basis.
I tend to think this may be offered by Teneo with a full wearable the long term solution.
Thanks for your post as it looks like the luck pendulum might go our way.
The Sanofi and Regen share price did not spike at all on news release.

Expand

Unifollower, I must say thank you for the regular industry updates, quite refreshing reading, away from the speculative negative noise, keep it up.

W

UNS Price at posting: 3.8¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

THL

Tourism Holdings says Liberation Day tariffs smashed US RV demand

Listen: HotCopper Wire Podcast 016 – FY25 ended up not so bad... but Trump unpause is coming

NMG

New Murchison Gold blasts off at Crown Prince as 'better than expected' results return

OSL

OncoSil wraps up recruitment for key pancreatic cancer trial

DMP

Is Domino's a steal after -25% plunge?

KGD

Kula picks up unexplored niobium play in Malawi, with surface samples logged

Trump chides Powell as Goldman call for calm. The RBA must be nervous

I88

Infini Resources onto Phase 2 at Portland Creek after spotting 'widespread uranium'

HotCopper Highlights, Week 27: G8 scalped, Domino’s drops the box, Gemlife brief hype & more

Week 27 Wrap: 40% China tariffs?; ASX +10% FY25; US Amazon price spike

First 9 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Dupilumab gets FDA approval, page-9

Top Stories

Tourism Holdings says Liberation Day tariffs smashed US RV demand

Listen: HotCopper Wire Podcast 016 – FY25 ended up not so bad... but Trump unpause is coming

New Murchison Gold blasts off at Crown Prince as 'better than expected' results return

OncoSil wraps up recruitment for key pancreatic cancer trial

Is Domino's a steal after -25% plunge?

Kula picks up unexplored niobium play in Malawi, with surface samples logged

Trump chides Powell as Goldman call for calm. The RBA must be nervous

Infini Resources onto Phase 2 at Portland Creek after spotting 'widespread uranium'

HotCopper Highlights, Week 27: G8 scalped, Domino’s drops the box, Gemlife brief hype & more

Week 27 Wrap: 40% China tariffs?; ASX +10% FY25; US Amazon price spike

Featured News